Lascuña, Judi Ann .
HRN: 26-72-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2025
CEFUROXIME 500MG (TAB)
09/29/2025
10/04/2025
PO
500mg
BID
NSVD With RMLE
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes